QA: Intra Cellular Therapies Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001567514_2024_Intra_Cellular_Therapies_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001567514, Intra Cellular Therapies Inc

  xvar xval
0 AssetsCurrent 667,799,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,654,000
3 remainder_Assets 58,842,000
4 LiabilitiesCurrent 123,545,000
5 LiabilitiesNoncurrent 13,326,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 579,087,286
9 ResearchAndDevelopmentExpense 182,859,112
10 remainder_Expenses 103,972,220
11 remainder_Revenues 1,534,261,345
12 remainder_NetIncome 15,989,819
13 remainder_ComprehensiveNetIncome -3,812,858
  yvar yval
0 Assets 728,295,000
1 Liabilities 136,871,000
2 Expenses 865,918,618
3 Revenues 1,534,261,345
4 StockholdersEquity 591,424,000
5 NetIncome 684,332,546
6 ComprehensiveNetIncome 682,426,117
7 BaseVar 1,642,574,320
8 EconomicCapitalRatiobeforeLimitedLiability 4.56
9 EconomicCapitalRatio 4.83

Edgar->Model Mapping

Feature Distribution

Change over Time